ArticleOncotarget2018

Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity.

Lydia A Hepburn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.